Murphy Pohlad Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.02M | Sell |
64,119
-2,098
| -3% | -$169K | 1.75% | 14 |
|
|
2026
Q1 | $5.74M | Sell |
66,217
-627
| -0.9% | -$60.1K | 2.06% | 11 |
|
|
2025
Q4 | $6.42M | Sell |
66,844
-250
| -0.4% | -$24.3K | 2.47% | 5 |
|
|
2025
Q3 | $6.39M | Buy |
67,094
+350
| +0.5% | +$32.2K | 2.51% | 4 |
|
|
2025
Q2 | $5.82M | Buy |
66,744
+340
| +0.5% | +$28.8K | 2.46% | 6 |
|
|
2025
Q1 | $5.97M | Sell |
66,404
-155
| -0.2% | -$13.9K | 2.53% | 5 |
|
|
2024
Q4 | $5.32M | Sell |
66,559
-1,725
| -3% | -$149K | 2.29% | 5 |
|
|
2024
Q3 | $6.15M | Sell |
68,284
-1,766
| -3% | -$149K | 2.56% | 4 |
|
|
2024
Q2 | $5.51M | Sell |
70,050
-8,625
| -11% | -$707K | 2.38% | 6 |
|
|
2024
Q1 | $6.86M | Buy |
78,675
+2,170
| +3% | +$185K | 2.68% | 5 |
|
|
2023
Q4 | $6.3M | Buy |
76,505
+2,508
| +3% | +$191K | 2.61% | 6 |
|
|
2023
Q3 | $5.8M | Buy |
73,997
+3,565
| +5% | +$298K | 2.54% | 7 |
|
|
2023
Q2 | $6.21M | Buy |
70,432
+800
| +1% | +$68.9K | 2.67% | 5 |
|
|
2023
Q1 | $5.61M | Buy |
69,632
+580
| +0.8% | +$47.3K | 2.33% | 9 |
|
|
2022
Q4 | $5.37M | Buy |
69,052
+875
| +1% | +$70.9K | 2.2% | 12 |
|
|
2022
Q3 | $5.5M | Sell |
68,177
-70
| -0.1% | -$6.29K | 2.55% | 8 |
|
|
2022
Q2 | $6.13M | Buy |
68,247
+1,675
| +3% | +$170K | 2.69% | 4 |
|
|
2022
Q1 | $7.39M | Buy |
66,572
+4,325
| +7% | +$457K | 2.98% | 3 |
|
|
2021
Q4 | $6.44M | Buy |
62,247
+1,335
| +2% | +$155K | 2.53% | 5 |
|
|
2021
Q3 | $7.63M | Hold |
60,912
| – | – | 3.12% | 4 |
|
|
2021
Q2 | $7.56M | Sell |
60,912
-830
| -1% | -$104K | 3.06% | 5 |
|
|
2021
Q1 | $7.29M | Buy |
61,742
+2,000
| +3% | +$234K | 3.18% | 4 |
|
|
2020
Q4 | $7M | Sell |
59,742
-2,200
| -4% | -$242K | 3.47% | 4 |
|
|
2020
Q3 | $6.44M | Buy |
61,942
+2,250
| +4% | +$226K | 3.42% | 4 |
|
|
2020
Q2 | $5.47M | Buy |
59,692
+880
| +1% | +$84.4K | 3.06% | 4 |
|
|
2020
Q1 | $5.3M | Buy |
58,812
+2,705
| +5% | +$288K | 3.61% | 3 |
|
|
2019
Q4 | $6.37M | Sell |
56,107
-780
| -1% | -$85.6K | 3.49% | 4 |
|
|
2019
Q3 | $6.18M | Sell |
56,887
-1,995
| -3% | -$208K | 3.77% | 2 |
|
|
2019
Q2 | $5.73M | Sell |
58,882
-2,010
| -3% | -$184K | 3.43% | 3 |
|
|
2019
Q1 | $5.55M | Sell |
60,892
-120
| -0.2% | -$10.7K | 3.35% | 3 |
|
|
2018
Q4 | $5.55M | Buy |
61,012
+295
| +0.5% | +$27.6K | 3.86% | 3 |
|
|
2018
Q3 | $5.97M | Sell |
60,717
-215
| -0.4% | -$19.9K | 3.67% | 2 |
|
|
2018
Q2 | $5.22M | Sell |
60,932
-80
| -0.1% | -$6.68K | 3.49% | 3 |
|
|
2018
Q1 | $4.89M | Buy |
61,012
+450
| +0.7% | +$37.1K | 3.37% | 5 |
|
|
2017
Q4 | $4.89M | Buy |
60,562
+1,100
| +2% | +$88.1K | 3.23% | 5 |
|
|
2017
Q3 | $4.62M | Buy |
59,462
+2,940
| +5% | +$244K | 3.22% | 5 |
|
|
2017
Q2 | $5.02M | Buy |
56,522
+920
| +2% | +$77.6K | 3.7% | 3 |
|
|
2017
Q1 | $4.48M | Buy |
55,602
+407
| +0.7% | +$31.8K | 3.31% | 4 |
|
|
2016
Q4 | $3.93M | Buy |
55,195
+10,251
| +23% | +$805K | 2.85% | 5 |
|
|
2016
Q3 | $3.88M | Sell |
44,944
-75
| -0.2% | -$6.54K | 2.88% | 5 |
|
|
2016
Q2 | $3.91M | Hold |
45,019
| – | – | 2.91% | 5 |
|
|
2016
Q1 | $3.38M | Sell |
45,019
-240
| -0.5% | -$18.1K | 2.54% | 10 |
|
|
2015
Q4 | $3.48M | Sell |
45,259
-1,750
| -4% | -$132K | 2.75% | 7 |
|
|
2015
Q3 | $3.15M | Sell |
47,009
-800
| -2% | -$58.9K | 2.56% | 7 |
|
|
2015
Q2 | $3.54M | Buy |
+47,809
| New | +$3.65M | 2.67% | 8 |
|
|
2015
Q1 | – | Sell |
-37,819
| Closed | -$2.73M | – | 93 |
|
|
2014
Q4 | $2.73M | Sell |
37,819
-21,914
| -37% | -$1.52M | 1.97% | 13 |
|
|
2014
Q3 | $3.7M | Sell |
59,733
-7,531
| -11% | -$479K | 2.87% | 6 |
|
|
2014
Q2 | $4.29M | Sell |
67,264
-1,705
| -2% | -$104K | 3.29% | 1 |
|
|
2014
Q1 | $4.24M | Sell |
68,969
-1,175
| -2% | -$68.4K | 3.44% | 1 |
|
|
2013
Q4 | $4.03M | Sell |
70,144
-760
| -1% | -$43.1K | 3.29% | 1 |
|
|
2013
Q3 | $3.77M | Hold |
70,904
| – | – | 3.37% | 1 |
|
|
2013
Q2 | $3.65M | Buy |
+70,904
| New | +$3.5M | 3.37% | 1 |
|
Other funds holding MDT
Murphy Pohlad Asset Management's MDT Position: Q2 2026 in Review
Murphy Pohlad Asset Management reduced its Medtronic (MDT) stake by 3.2% in Q2 2026, selling an estimated $169K and leaving 64,119 shares worth $5.02M. The position accounts for 1.75% of the portfolio, ranked #14.
Murphy Pohlad Asset Management first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.63M in Q3 2021. 2,131 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Murphy Pohlad Asset Management held 64,119 shares of Medtronic worth $5.02M as of Q2 2026.
- Murphy Pohlad Asset Management sold 2,098 Medtronic shares in Q2 2026, an estimated $169K.
- Medtronic made up 1.75% of Murphy Pohlad Asset Management's portfolio in Q2 2026, its #14 holding.
- Murphy Pohlad Asset Management first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
- Murphy Pohlad Asset Management's Medtronic position peaked at $7.63M in Q3 2021.
- 2,131 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Murphy Pohlad Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.